1. Home /
  2. Biotechnology


A 'Trip' to the Boardroom: A Look at Psychedelic Med's Top Players

To help readers navigate this mushrooming opportunity, I've put together a list of the top corporate leaders in the field.

Insider Buying Picks Up in These Biotech Stocks

The beaten-down biotech sector had one of the best weeks in a year. Are these names still oversold?

There's Good News for 3 Biotech Names

And It comes after one of the best days of the year for the biotech sector.

Would-Be Buyers Should Wait for a Dip in Bullish Prothena

The shares of the under-the-radar biotech have had a strong run in recent months, so traders might want to watch for a pullback to buy.

Jim Cramer: Why Hasn't the Government Pushed for Mass Vaccination?

Incompetence, omissions and even outright lies have categorized this federal attempt to 'stem' the pandemic.

Biotech Bounces

Let's look at the moves in the exchange-traded funds for the sector -- and check on the utilities and mega-caps.

Does Cardiff Oncology Pass the Speculative Test?

After watching the moves in Trillium Therapeutics, a Real Money reader wants to play CRDF. Here's the what the charts say.

Henri, Fiscal and Monetary Uncertainty, Vaccine Update, Trading Nvidia and AMD

Investors come into this week with 'all eyes' on the Kansas City Fed's economic symposium come week's end.

Taiwan Administers First Home-Made Vaccine

Watch Medigen stock, as the Taiwanese president becomes one of the first citizens of the island nation to roll up her sleeve.

2 Drooping Pharma Stocks That Need to Put More Chips on the Table

Supernus Pharmaceuticals and Exelixis Inc. have the cash to be able to take some chances in order to improve their business prospects.